123 related articles for article (PubMed ID: 10465558)
1. Ring E analogs of methyllycaconitine (MLA) as novel nicotinic antagonists.
Bergmeier SC; Lapinsky DJ; Free RB; McKay DB
Bioorg Med Chem Lett; 1999 Aug; 9(15):2263-6. PubMed ID: 10465558
[TBL] [Abstract][Full Text] [Related]
2. Structure activity studies of ring E analogues of methyllycaconitine. Part 2: Synthesis of antagonists to the alpha3beta4* nicotinic acetylcholine receptors through modifications to the ester.
Bergmeier SC; Ismail KA; Arason KM; McKay S; Bryant DL; McKay DB
Bioorg Med Chem Lett; 2004 Jul; 14(14):3739-42. PubMed ID: 15203153
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity studies with ring E analogues of methyllycaconitine. Synthesis and evaluation of enantiopure isomers of selective antagonist at the alpha3 nicotinic receptor.
Ismail KA; Bergmeier SC
Eur J Med Chem; 2002 Jun; 37(6):469-74. PubMed ID: 12204473
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies with ring E analogues of methyllycaconitine on bovine adrenal alpha3beta4* nicotinic receptors.
Bryant DL; Free RB; Thomasy SM; Lapinsky DJ; Ismail KA; McKay SB; Bergmeier SC; McKay DB
Neurosci Res; 2002 Jan; 42(1):57-63. PubMed ID: 11814609
[TBL] [Abstract][Full Text] [Related]
5. Analogs of methyllycaconitine as novel noncompetitive inhibitors of nicotinic receptors: pharmacological characterization, computational modeling, and pharmacophore development.
McKay DB; Chang C; González-Cestari TF; McKay SB; El-Hajj RA; Bryant DL; Zhu MX; Swaan PW; Arason KM; Pulipaka AB; Orac CM; Bergmeier SC
Mol Pharmacol; 2007 May; 71(5):1288-97. PubMed ID: 17308033
[TBL] [Abstract][Full Text] [Related]
6. Effects of methyllycaconitine and related analogues on bovine adrenal alpha3beta4* nicotinic acetylcholine receptors.
Bryant DL; Free RB; Thomasy SM; Lapinsky DJ; Ismail KA; Arason KM; Bergmeier SC; McKay DB
Ann N Y Acad Sci; 2002 Oct; 971():139-41. PubMed ID: 12438104
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.
Jensen AA; Zlotos DP; Liljefors T
J Med Chem; 2007 Sep; 50(19):4616-29. PubMed ID: 17722904
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity studies of bicyclic and tricyclic analogues of methyllycaconitine.
Davies AR; Hardick DJ; Blagbrough IS; Potter BV; Wolstenholme AJ; Wonnacott S
Biochem Soc Trans; 1997 Aug; 25(3):545S. PubMed ID: 9388759
[No Abstract] [Full Text] [Related]
9. Cotinine binding to nicotinic acetylcholine receptors in bovine chromaffin cell and rat brain membranes.
Vainio PJ; Tuominen RK
Nicotine Tob Res; 2001 May; 3(2):177-82. PubMed ID: 11403732
[TBL] [Abstract][Full Text] [Related]
10. Conversion of the sodium channel activator aconitine into a potent alpha 7-selective nicotinic ligand.
Hardick DJ; Cooper G; Scott-Ward T; Blagbrough IS; Potter BV; Wonnacott S
FEBS Lett; 1995 May; 365(1):79-82. PubMed ID: 7774720
[TBL] [Abstract][Full Text] [Related]
11. Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum.
Mogg AJ; Whiteaker P; McIntosh JM; Marks M; Collins AC; Wonnacott S
J Pharmacol Exp Ther; 2002 Jul; 302(1):197-204. PubMed ID: 12065717
[TBL] [Abstract][Full Text] [Related]
12. Methyllycaconitine analogues have mixed antagonist effects at nicotinic acetylcholine receptors.
Barker D; Lin DH; Carland JE; Chu CP; Chebib M; Brimble MA; Savage GP; McLeod MD
Bioorg Med Chem; 2005 Jul; 13(14):4565-75. PubMed ID: 15922601
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, nicotinic acetylcholine receptor binding, antinociceptive and seizure properties of methyllycaconitine analogs.
Ivy Carroll F; Ma W; Navarro HA; Abraham P; Wolckenhauer SA; Damaj MI; Martin BR
Bioorg Med Chem; 2007 Jan; 15(2):678-85. PubMed ID: 17098430
[TBL] [Abstract][Full Text] [Related]
14. Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors.
Escubedo E; Chipana C; Pérez-Sánchez M; Camarasa J; Pubill D
J Pharmacol Exp Ther; 2005 Nov; 315(2):658-67. PubMed ID: 16076935
[TBL] [Abstract][Full Text] [Related]
15. Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.
Crooks PA; Ayers JT; Xu R; Sumithran SP; Grinevich VP; Wilkins LH; Deaciuc AG; Allen DD; Dwoskin LP
Bioorg Med Chem Lett; 2004 Apr; 14(8):1869-74. PubMed ID: 15050618
[TBL] [Abstract][Full Text] [Related]
16. Nicotine cue: lack of effect of the alpha 7 nicotinic receptor antagonist methyllycaconitine.
Brioni JD; Kim DJ; O'Neill AB
Eur J Pharmacol; 1996 Apr; 301(1-3):1-5. PubMed ID: 8773440
[TBL] [Abstract][Full Text] [Related]
17. Neuronal nicotinic alpha 7 receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine.
Palma E; Bertrand S; Binzoni T; Bertrand D
J Physiol; 1996 Feb; 491 ( Pt 1)(Pt 1):151-61. PubMed ID: 9011607
[TBL] [Abstract][Full Text] [Related]
18. The alpha7 nicotinic acetylcholine receptor-selective antagonist, methyllycaconitine, partially protects against beta-amyloid1-42 toxicity in primary neuron-enriched cultures.
Martin SE; de Fiebre NE; de Fiebre CM
Brain Res; 2004 Oct; 1022(1-2):254-6. PubMed ID: 15353238
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of the actions of acetylcholine, epibatidine, and nicotine by methyllycaconitine at fetal muscle-type nicotinic acetylcholine receptors.
Green BT; Welch KD; Cook D; Gardner DR
Eur J Pharmacol; 2011 Jul; 662(1-3):15-21. PubMed ID: 21554871
[TBL] [Abstract][Full Text] [Related]
20. Methyllycaconitine-, alpha-bungarotoxin-sensitive neuronal nicotinic receptor operates slow calcium signal in skeletal muscle end plate.
Kimura I; Dezaki K
Ann N Y Acad Sci; 1999 Apr; 868():624-7. PubMed ID: 10414344
[No Abstract] [Full Text] [Related]
[Next] [New Search]
